WashingtonVotes.org
your lawmakers' votes at your fingertips
your lawmakers' votes at your fingertips
Legislation watch
2017 House Bill 1541: Addressing prescription drug cost transparency
Introduced by Rep. June Robinson (Everett) (D) on January 23, 2017
Referred to the House Health Care & Wellness Committee on January 23, 2017
Substitute offered in the House on February 17, 2017
Requires issuers and drug manufacturers to report certain prescription drug pricing data to a data organization contracted by the Office of Financial Management (OFM).
Referred to the House Appropriations Committee on February 17, 2017
Substitute offered in the House on February 24, 2017
The Office of Financial Management (OFM) must use a competitive procurement process to select a data organization to collect, verify, and summarize prescription drug pricing data provided by issuers and drug manufacturers. "Prescription drugs" include generic, brand name, and specialty drugs, as well as biological products.
Received in the Senate on March 8, 2017
Referred to the Senate Health Care Committee on March 8, 2017
Received in the House on January 8, 2018
Referred to the House Rules Committee on January 8, 2018
Received in the Senate on February 9, 2018
Referred to the Senate Health & Long-Term Care Committee on February 9, 2018
Referred to the Senate Ways & Means Committee on February 23, 2018
Referred to the Senate Rules Committee on February 26, 2018